Chen Z, Yu D, Owonikoko TK, Ramalingam SS, et al. Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib. Oncogene 2021;40:6653-6665.
PMID: 34635799